abrdn World Healthcare Fund (THW) shareholders
Close on Nov 13, 2026Market cap –P/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of THW | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Morgan Stanley | 1,126,037 | – | $15.09M | +11,658 | 0.00% |
| Penserra Capital Management LLC | 667,148 | – | $8.94M | +25,445 | 0.07% |
| Royal Bank of Canada | 462,541 | – | $6.20M | −295 | 0.00% |
| Raymond James Financial Inc | 310,343 | – | $4.16M | +38,774 | 0.00% |
| LPL Financial LLC | 280,297 | – | $3.76M | −743 | 0.00% |
| Janney Montgomery Scott LLC | 253,887 | – | $3.40M | −3,866 | 0.01% |
| CoreCap Advisors, LLC | 245,720 | – | $3.29M | −11,306 | 0.10% |
| Commonwealth Equity Services, LLC | 232,241 | – | $3.11M | −4,694 | 0.00% |
| Steward Partners Investment Advisory, LLC | 169,075 | – | $2.27M | +4,234 | 0.01% |
| Significant Wealth Partners LLC | 147,758 | – | $1.98M | +2,577 | 2.14% |
| International Assets Investment Management, LLC | 138,561 | – | $1.86M | +4,602 | 0.11% |
| Osaic Holdings, Inc. | 137,694 | – | $1.85M | +57,234 | 0.00% |
| J.W. Cole Advisors, Inc. | 108,670 | – | $1.46M | New | 0.02% |
| Cetera Investment Advisers | 92,648 | – | $1.24M | +6,650 | 0.00% |
| NewEdge Wealth, LLC | 86,800 | – | $1.16M | – | 0.01% |
| UBS Group AG | 83,648 | – | $1.12M | −2,681 | 0.00% |
| Stifel Financial Corp | 79,553 | – | $1.07M | +8,568 | 0.00% |
| Wedbush Securities Inc | 76,764 | – | $1.03M | −875 | 0.03% |
| NewEdge Advisors, LLC | 69,396 | – | $929.90K | −1,027 | 0.00% |
| AlphaCore Capital LLC | 56,336 | – | $754.90K | +984 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 79 | 6M | 8 / 23 | 24 / 11 | 0M | 0M |
| Q1 2026 | 84 | 6M | 16 / 25 | 19 / 13 | 1M | 1M |
| Q4 2025 | 84 | 7M | 13 / 31 | 17 / 7 | 1M | 0M |
| Q3 2025 | 79 | 6M | 10 / 32 | 18 / 9 | 1M | 1M |
| Q2 2025 | 78 | 6M | 10 / 32 | 17 / 10 | 1M | 0M |
| Q1 2025 | 78 | 5M | 11 / 29 | 19 / 16 | 1M | 1M |
| Q4 2024 | 85 | 5M | 26 / 19 | 22 / 5 | 1M | 1M |
| Q3 2024 | 66 | 5M | 8 / 17 | 25 / 5 | 1M | 0M |
| Q2 2024 | 63 | 4M | 6 / 23 | 21 / 9 | 0M | 2M |
| Q1 2024 | 66 | 6M | 7 / 23 | 16 / 12 | 1M | 1M |
| Q4 2023 | 73 | 5M | 9 / 21 | 25 / 10 | 1M | 1M |
| Q3 2023 | 74 | 5M | 11 / 29 | 17 / 6 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
1 funds held THW in Q2 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of THW | Value | % of fund | As of |
|---|---|---|---|---|---|
| Amplify CEF High Income ETF | 663,968 | – | $8.90M | 1.23% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Heather Carter Reilly | Vice President | – | Dec 19, 2025 |
| Heather Rose Hasson | Vice President | – | Mar 20, 2025 |
| Andrew Wonil Kim | Vice President | – | Mar 20, 2025 |
| Robert W. Hepp | Vice President | – | Mar 20, 2025 |
| Michael Marsico | Vice President | – | Mar 20, 2025 |
| Michael Taggart | Vice President | – | Mar 20, 2025 |
| Katie Lynn Gebauer | Vice President | – | Mar 20, 2025 |
| Ashton Wilson | Vice President | – | Dec 20, 2024 |
| Kolotioloma Silue | Vice President | – | Dec 20, 2024 |
| Chris LaVictoire Mahai | Director | 796 | Jul 20, 2026 |
| Joseph Francis Dietrick | – | – | Jul 22, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Chris LaVictoire Mahai Director | Jul 16, 2026 | Buy | +796 | $13.20 | $10.51K | 796 |
| Bill Maher Director | Aug 14, 2024 | Buy | +1,000 | $13.03 | $13.03K | 1,000 |
| Rose DiMartino Director | Jul 16, 2024 | Buy | +1,000 | $13.31 | $13.31K | 1,000 |
| Kathleen Goetz Director | Apr 9, 2024 | Buy | +200 | $12.53 | $2.51K | 1,017 |
| Todd Reit Director | Jan 2, 2024 | Buy | +1,000 | $11.94 | $11.94K | 1,000 |
| Kathleen Goetz Director | Mar 23, 2022 | Buy | +103.38 | $14.52 | $1.50K | 817 |
| Kathleen Goetz Director | Jan 26, 2022 | Buy | +714 | $14.60 | $10.42K | 714 |
| William S. Reardon Director | Apr 6, 2021 | Option exercise | +486 | $14.26 | $6.93K | 1,946 |
| Lucinda H. Stebbins Director | Apr 6, 2021 | Option exercise | +250 | $14.26 | $3.57K | 1,000 |
| Daniel R. Omstead President, Director | Apr 6, 2021 | Option exercise | +6,442 | $14.26 | $91.86K | 30,768 |
| Thomas M. Kent Director | Apr 6, 2021 | Option exercise | +600 | $14.26 | $8.56K | 2,400 |
| Jeffrey Allen Bailey Director | Apr 6, 2021 | Option exercise | +245 | $14.26 | $3.49K | 980 |
| William S. Reardon Director | Feb 25, 2021 | Buy | +1,460 | $17.14 | $25.02K | 1,460 |
| Lucinda H. Stebbins Director | Feb 19, 2021 | Buy | +750 | $16.80 | $12.60K | 750 |
| Jeffrey Allen Bailey Director | Sep 23, 2020 | Buy | +710 | $14.18 | $10.07K | 710 |
| Daniel R. Omstead President, Director | Mar 17, 2020 | Buy | +9,926 | $10.77 | $106.90K | 24,326 |
| Daniel R. Omstead President, Director | Dec 26, 2018 | Buy | +9,400 | $11.11 | $104.43K | 14,400 |
| Thomas M. Kent Director | Jan 25, 2018 | Buy | +1,800 | $14.52 | $26.14K | 1,800 |
| Timothy L. Gasperoni – | Jan 6, 2016 | Buy | +1,592 | $15.72 | $25.03K | 1,592 |
| Michael W. Bonney Director | Aug 17, 2015 | Buy | +10,917 | $18.35 | $200.33K | 10,917 |
| Daniel R. Omstead President, Director | Jun 25, 2015 | Buy | +5,000 | $20.00 | $100.00K | 5,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of abrdn World Healthcare Fund's stock actually held short. Settlement fails (shares not delivered on time) peaked at 72 shares on Sep 22, 2026 over the last 90 days.
See a number that looks wrong?